Trials / Completed
CompletedNCT03003000
Ibuprofen/Caffeine Lower Back or Neck Pain Study
A Randomized, Placebo- and Active-controlled Multi-country, Multi-centre Parallel Group Study to Evaluate the Efficacy and Safety of a Fixed Dose Combination of 400 mg Ibuprofen and 100 mg Caffeine Compared to Ibuprofen 400 mg and Placebo in Patients With Acute Lower Back or Neck Pain.
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 635 (actual)
- Sponsor
- Boehringer Ingelheim · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To assess the efficacy and safety of a 400 mg ibuprofen/100 mg caffeine tablet in comparison to a 400 mg ibuprofen tablet for the treatment of acute lower back or neck pain. To assess the safety and tolerability of a 400 mg ibuprofen/100 mg caffeine tablet in comparison to a 400 mg ibuprofen tablet and a placebo tablet.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ibuprofen | |
| DRUG | caffeine | |
| DRUG | placebo |
Timeline
- Start date
- 2016-12-20
- Primary completion
- 2017-09-24
- Completion
- 2017-09-28
- First posted
- 2016-12-26
- Last updated
- 2019-06-07
- Results posted
- 2019-06-07
Locations
18 sites across 2 countries: Germany, Russia
Source: ClinicalTrials.gov record NCT03003000. Inclusion in this directory is not an endorsement.